Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.
Eur J Clin Invest. 2015 Apr;45(4):423-40. doi: 10.1111/eci.12419. Epub 2015 Mar 9.
Eur J Clin Invest. 2015.
PMID: 25678219
Free PMC article.
Review.